Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

HRT soon after menopause may cut dementia risk

  • Comment

The risk of dementia in women may be reduced if they are given hormone replacement therapy (HRT) soon after the menopause.

Treatment with HRT prevented degeneration in key regions of the brain in women at heightened risk of dementia, according to a small study published in the journal PLOS One.

Women were defined as being at a heightened risk of dementia if they had a history of major depression, had a first-degree relative with the condition or carried the Apo4 allele gene.

Apo4 is a gene variant known to significantly increase a person’s risk of developing Alzheimer’s disease.

“This particular study indicates that the use of HRT, especially estradiol, may protect area of the brain associated with dementia in women”

Doug Brown

The research was led by Natalie Rasgon from Stanford University School of Medicine. There were 45 post-menopausal women who remained in the study, 28 of whom continued with HRT while 17 stopped using it.

Brain images were taken at the beginning of the study and two years later. The scans indicated that metabolic activity in the medial prefrontal cortex − essential to decision making − was better preserved among the women who remained on HRT.

There were two HRT drugs taken by women in the study and the researchers discovered that pure estradiol and Premarin − a brand name part made up of estradiol − were associated with the biggest effect in preserving metabolic activity.

Dr Doug Brown, director of research and development at the Alzheimer’s Society, said several previous studies have generated “mixed” results but this latest research “indicates that the use of HRT, especially estradiol, may protect area of the brain associated with dementia in women”.

He continued: “It’s important to note, however, that the study size was very small and no one in the study experienced cognitive decline despite being at risk, making it hard to draw any solid conclusions about how it would affect their risk of developing dementia.”

On the basis of this study the charity said it would not recommend women take HRT with the aim of reducing their dementia risk but “it would be interesting to see more research in this area”.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs